{
    "2019-05-03": [
        [
            {
                "time": "",
                "original_text": "摩通：首予药明康德(02359.HK)“增持”评级 目标价115港元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "增持",
                        "目标价",
                        "115港元"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}